Skip to main content

Animations

MJFF Publications

4911 - 4920 of 8785 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2025
  • 2025
  • 2025
  • Summary Details
    OPEN
    Title: Shared mechanisms across the major psychiatric and neurodegenerative diseases
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-022-31873-5
    Citation Count: 135
  • Summary Details
    RESTRICTED
    Title: Parkinson’s disease drug hunters think outside the α-synuclein box
    Journal Name: Nature Biotechnology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/s41587-022-01610-w
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Integrative analysis of non-small cell lung cancer patient-derived xenografts identifies distinct proteotypes associated with patient outcomes
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-022-29444-9
    Citation Count: 39
  • Summary Details
    OPEN
    Title: Preclinical and randomized clinical evaluation of the p38α kinase inhibitor neflamapimod for basal forebrain cholinergic degeneration
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-022-32944-3
    Citation Count: 43
  • Summary Details
    OPEN
    Title: Satellite repeat transcripts modulate heterochromatin condensates and safeguard chromosome stability in mouse embryonic stem cells
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-022-31198-3
    Citation Count: 47
  • Summary Details
    OPEN
    Title: Metagenomics of Parkinson’s disease implicates the gut microbiome in multiple disease mechanisms
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-022-34667-x
    Citation Count: 218
  • Summary Details
    OPEN
    Title: Artificial intelligence-enabled detection and assessment of Parkinson’s disease using nocturnal breathing signals
    Journal Name: Nature Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41591-022-01932-x
    Citation Count: 208
  • Summary Details
    OPEN
    Title: Association between serum sodium and sporadic Parkinson’s disease
    Journal Name: Frontiers in Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnins.2025.1555831
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Dopamine Transporter Imaging as Objective Monitoring Biomarker in Parkinson's Disease
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/ana.27223
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Trajectories of Pontine Volume in Patients with Multiple System Atrophy
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.30182
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.